1	Evidence	evidence	_	_	_	_	_	_	_
2	for	for	_	_	_	_	_	_	_
3	lowered	lowered	_	_	_	_	_	_	_
4	induction	induction	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	nuclear	nuclear	_	_	_	_	_	_	_
7	factor	factor	_	_	_	_	_	_	_
8	kappa	kappa	_	_	_	_	_	_	_
9	B	b	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	activated	activate	_	_	_	_	_	_	_
12	human	human	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	lymphocytes	lymphocyte	_	_	_	_	_	_	_
15	during	during	_	_	_	_	_	_	_
16	aging	aging	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	Transcription	Transcription	_	_	_	_	_	_	_
2	factor	factor	_	_	_	_	_	_	_
3	NF	NF	_	_	_	_	_	_	_
4	kappa	kappa	_	_	_	_	_	_	_
5	B	B	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	nuclear	nuclear	_	_	_	_	_	_	_
8	factor	factor	_	_	_	_	_	_	_
9	kappa	kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	induced	induce	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	T	t	_	_	_	_	_	_	_
16	lymphocytes	lymphocyte	_	_	_	_	_	_	_
17	from	from	_	_	_	_	_	_	_
18	young	young	_	_	_	_	_	_	_
19	individuals	individual	_	_	_	_	_	_	_
20	following	follow	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	with	with	_	_	_	_	_	_	_
23	a	a	_	_	_	_	_	_	_
24	variety	variety	_	_	_	_	_	_	_
25	of	of	_	_	_	_	_	_	_
26	stimuli	stimulus	_	_	_	_	_	_	_
27	including	include	_	_	_	_	_	_	_
28	anti-CD3	anti-cd3	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	phorbol	phorbol	_	_	_	_	_	_	_
31	myristate	myristate	_	_	_	_	_	_	_
32	acetate	acetate	_	_	_	_	_	_	_
33	(	(	_	_	_	_	_	_	_
34	PMA	PMA	_	_	_	_	_	_	_
35	)	)	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	tumor	tumor	_	_	_	_	_	_	_
39	necrosis	necrosis	_	_	_	_	_	_	_
40	factor-alpha	factor-alpha	_	_	_	_	_	_	_
41	(	(	_	_	_	_	_	_	_
42	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
43	)	)	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	activated	activate	_	_	_	_	_	_	_
5	T	t	_	_	_	_	_	_	_
6	lymphocytes	lymphocyte	_	_	_	_	_	_	_
7	from	from	_	_	_	_	_	_	_
8	older	old	_	_	_	_	_	_	_
9	individuals	individual	_	_	_	_	_	_	_
10	show	show	_	_	_	_	_	_	_
11	a	a	_	_	_	_	_	_	_
12	significant	significant	_	_	_	_	_	_	_
13	reduction	reduction	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	induction	induction	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	NF	NF	_	_	_	_	_	_	_
19	kappa	kappa	_	_	_	_	_	_	_
20	B	B	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	response	response	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	same	same	_	_	_	_	_	_	_
26	stimuli	stimulus	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	age-related	age-related	_	_	_	_	_	_	_
3	decline	decline	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	induction	induction	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	NF	NF	_	_	_	_	_	_	_
8	kappa	kappa	_	_	_	_	_	_	_
9	B	B	_	_	_	_	_	_	_
10	could	could	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	be	be	_	_	_	_	_	_	_
13	attributed	attribute	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	alteration	alteration	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	the	the	_	_	_	_	_	_	_
18	composition	composition	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	subunits	subunit	_	_	_	_	_	_	_
21	,	,	_	_	_	_	_	_	_
22	p50	p50	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	p65	p65	_	_	_	_	_	_	_
25	were	be	_	_	_	_	_	_	_
26	found	find	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	be	be	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	predominant	predominant	_	_	_	_	_	_	_
31	subunits	subunit	_	_	_	_	_	_	_
32	of	of	_	_	_	_	_	_	_
33	induced	induce	_	_	_	_	_	_	_
34	NF	NF	_	_	_	_	_	_	_
35	kappa	kappa	_	_	_	_	_	_	_
36	B	b	_	_	_	_	_	_	_
37	in	in	_	_	_	_	_	_	_
38	T	t	_	_	_	_	_	_	_
39	cells	cell	_	_	_	_	_	_	_
40	from	from	_	_	_	_	_	_	_
41	young	young	_	_	_	_	_	_	_
42	as	as	_	_	_	_	_	_	_
43	well	well	_	_	_	_	_	_	_
44	as	as	_	_	_	_	_	_	_
45	elderly	elderly	_	_	_	_	_	_	_
46	donors	donor	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	similar	similar	_	_	_	_	_	_	_
4	levels	level	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	NF	NF	_	_	_	_	_	_	_
7	kappa	kappa	_	_	_	_	_	_	_
8	B	B	_	_	_	_	_	_	_
9	were	be	_	_	_	_	_	_	_
10	found	find	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	cytosols	cytosol	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	unactivated	unactivated	_	_	_	_	_	_	_
16	T	t	_	_	_	_	_	_	_
17	cells	cell	_	_	_	_	_	_	_
18	from	from	_	_	_	_	_	_	_
19	both	both	_	_	_	_	_	_	_
20	young	young	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	elderly	elderly	_	_	_	_	_	_	_
23	donors	donor	_	_	_	_	_	_	_
24	suggesting	suggest	_	_	_	_	_	_	_
25	that	that	_	_	_	_	_	_	_
26	precursor	precursor	_	_	_	_	_	_	_
27	levels	level	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	NF	NF	_	_	_	_	_	_	_
30	kappa	kappa	_	_	_	_	_	_	_
31	B	B	_	_	_	_	_	_	_
32	remain	remain	_	_	_	_	_	_	_
33	unaltered	unaltered	_	_	_	_	_	_	_
34	during	during	_	_	_	_	_	_	_
35	aging	aging	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	an	an	_	_	_	_	_	_	_
6	age-associated	age-associated	_	_	_	_	_	_	_
7	decline	decline	_	_	_	_	_	_	_
8	in	in	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	induction	induction	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	NF	NF	_	_	_	_	_	_	_
13	kappa	kappa	_	_	_	_	_	_	_
14	B	B	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	activated	activate	_	_	_	_	_	_	_
17	T	t	_	_	_	_	_	_	_
18	cells	cell	_	_	_	_	_	_	_
19	from	from	_	_	_	_	_	_	_
20	elderly	elderly	_	_	_	_	_	_	_
21	individuals	individual	_	_	_	_	_	_	_
22	may	may	_	_	_	_	_	_	_
23	be	be	_	_	_	_	_	_	_
24	attributable	attributable	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	altered	altered	_	_	_	_	_	_	_
27	regulation	regulation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	the	the	_	_	_	_	_	_	_
30	inhibitor	inhibitor	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	I	i	_	_	_	_	_	_	_
33	kappa	kappa	_	_	_	_	_	_	_
34	B	B	_	_	_	_	_	_	_
35	,	,	_	_	_	_	_	_	_
36	and	and	_	_	_	_	_	_	_
37	may	may	_	_	_	_	_	_	_
38	play	play	_	_	_	_	_	_	_
39	an	an	_	_	_	_	_	_	_
40	important	important	_	_	_	_	_	_	_
41	role	role	_	_	_	_	_	_	_
42	in	in	_	_	_	_	_	_	_
43	immune	immune	_	_	_	_	_	_	_
44	dysregulation	dysregulation	_	_	_	_	_	_	_
45	accompanying	accompany	_	_	_	_	_	_	_
46	aging	aging	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

